245 related articles for article (PubMed ID: 9131008)
21. Study of CD40 ligand expression in B-cell chronic lymphocytic leukemia.
Brugnoni D; Rossi G; Tucci A; Cattaneo R; Airò P
Haematologica; 1995; 80(5):440-2. PubMed ID: 8566887
[TBL] [Abstract][Full Text] [Related]
22. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells.
Bairey O; Vanichkin A; Shpilberg O
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e77-85. PubMed ID: 19208092
[TBL] [Abstract][Full Text] [Related]
23. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein.
Wang H; Grand RJ; Milner AE; Armitage RJ; Gordon J; Gregory CD
Oncogene; 1996 Jul; 13(2):373-9. PubMed ID: 8710376
[TBL] [Abstract][Full Text] [Related]
24. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
26. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
27. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.
Kiener PA; Moran-Davis P; Rankin BM; Wahl AF; Aruffo A; Hollenbaugh D
J Immunol; 1995 Nov; 155(10):4917-25. PubMed ID: 7594496
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.
Willimott S; Merriam T; Wagner SD
Biochem Biophys Res Commun; 2011 Feb; 405(3):480-5. PubMed ID: 21256112
[TBL] [Abstract][Full Text] [Related]
30. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.
Holder MJ; Wang H; Milner AE; Casamayor M; Armitage R; Spriggs MK; Fanslow WC; MacLennan IC; Gregory CD; Gordon J
Eur J Immunol; 1993 Sep; 23(9):2368-71. PubMed ID: 8103750
[TBL] [Abstract][Full Text] [Related]
31. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
32. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
Péguet-Navarro J; Dalbiez-Gauthier C; Moulon C; Berthier O; Réano A; Gaucherand M; Banchereau J; Rousset F; Schmitt D
J Immunol; 1997 Jan; 158(1):144-52. PubMed ID: 8977185
[TBL] [Abstract][Full Text] [Related]
33. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.
Plander M; Seegers S; Ugocsai P; Diermeier-Daucher S; Iványi J; Schmitz G; Hofstädter F; Schwarz S; Orsó E; Knüchel R; Brockhoff G
Leukemia; 2009 Nov; 23(11):2118-28. PubMed ID: 19657365
[TBL] [Abstract][Full Text] [Related]
34. Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor.
Kobayashi R; Rassenti LZ; Meisenholder G; Carson DA; Kipps TJ
J Immunol; 1993 Dec; 151(12):7273-83. PubMed ID: 7505024
[TBL] [Abstract][Full Text] [Related]
35. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
[TBL] [Abstract][Full Text] [Related]
36. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'.
Planken EV; Dijkstra NH; Willemze R; Kluin-Nelemans JC
Leukemia; 1996 Mar; 10(3):488-93. PubMed ID: 8642867
[TBL] [Abstract][Full Text] [Related]
37. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells.
Huang RW; Tsuda H; Takatsuki K
Int J Hematol; 1993 Aug; 58(1-2):83-92. PubMed ID: 8219114
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
[TBL] [Abstract][Full Text] [Related]
40. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]